These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18577547)

  • 41. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.
    Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M
    J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levodopa and the feedback process on set-shifting in Parkinson's disease.
    Au WL; Zhou J; Palmes P; Sitoh YY; Tan LC; Rajapakse JC
    Hum Brain Mapp; 2012 Jan; 33(1):27-39. PubMed ID: 21438075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
    Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
    van Eimeren T; Ballanger B; Pellecchia G; Miyasaki JM; Lang AE; Strafella AP
    Neuropsychopharmacology; 2009 Dec; 34(13):2758-66. PubMed ID: 19741594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI.
    MacDonald PA; MacDonald AA; Seergobin KN; Tamjeedi R; Ganjavi H; Provost JS; Monchi O
    Brain; 2011 May; 134(Pt 5):1447-63. PubMed ID: 21596772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
    Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
    Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease.
    Kehagia AA; Cools R; Barker RA; Robbins TW
    Neuropsychologia; 2009 Mar; 47(4):1117-27. PubMed ID: 19166864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients.
    Shook SK; Franz EA; Higginson CI; Wheelock VL; Sigvardt KA
    Neuropsychologia; 2005; 43(14):1990-9. PubMed ID: 16243049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.
    Williams-Gray CH; Hampshire A; Barker RA; Owen AM
    Brain; 2008 Feb; 131(Pt 2):397-408. PubMed ID: 18178571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
    Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
    JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Motivation, reward, and Parkinson's disease: influence of dopatherapy.
    Czernecki V; Pillon B; Houeto JL; Pochon JB; Levy R; Dubois B
    Neuropsychologia; 2002; 40(13):2257-67. PubMed ID: 12417456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions.
    Rowe J; Stephan KE; Friston K; Frackowiak R; Lees A; Passingham R
    Brain; 2002 Feb; 125(Pt 2):276-89. PubMed ID: 11844728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combined effect of subthalamic nuclei deep brain stimulation and L-dopa increases emotion recognition in Parkinson's disease.
    Mondillon L; Mermillod M; Musca SC; Rieu I; Vidal T; Chambres P; Auxiette C; Dalens H; Marie Coulangeon L; Jalenques I; Lemaire JJ; Ulla M; Derost P; Marques A; Durif F
    Neuropsychologia; 2012 Oct; 50(12):2869-2879. PubMed ID: 22944002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.
    Mohl B; Berman BD; Shelton E; Tanabe J
    J Comp Neurol; 2017 Jun; 525(9):2192-2201. PubMed ID: 28256710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional imaging of sequence learning in Parkinson's disease.
    Carbon M; Eidelberg D
    J Neurol Sci; 2006 Oct; 248(1-2):72-7. PubMed ID: 16753182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How does reward expectation influence cognition in the human brain?
    Rowe JB; Eckstein D; Braver T; Owen AM
    J Cogn Neurosci; 2008 Nov; 20(11):1980-92. PubMed ID: 18416677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease.
    Schubert T; Volkmann J; Müller U; Sturm V; Voges J; Freund HJ; Von Cramon DY
    Exp Brain Res; 2002 May; 144(1):8-16. PubMed ID: 11976755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
    Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
    Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.